Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents
- PMID: 21497959
- DOI: 10.1016/j.ejmech.2011.03.058
Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents
Abstract
A new series of heterobivalent tacrine derivatives were designed, synthesized and evaluated as potential multi-functional anti-Alzheimer agents for their inhibitory activity on cholinesterases, antioxidant activity and self-induced β-amyloid (Aβ) aggregation. All these synthesized compounds had potent inhibition activity on acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) at nanomolar range. A Lineweaver-Burk plot and molecular modeling study showed that these compounds targeted both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE. The compounds containing hydroxyl group showed potent peroxyl radical absorbance activity. In addition, compound 5j exhibited higher self-induced Aβ aggregation inhibitory activity than curcumin, which could become a multi-functional agent for further development for the treatment of AD.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation.Bioorg Med Chem. 2011 Jan 15;19(2):763-70. doi: 10.1016/j.bmc.2010.12.022. Epub 2010 Dec 13. Bioorg Med Chem. 2011. PMID: 21211982
-
Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.Bioorg Med Chem. 2013 Dec 1;21(23):7275-82. doi: 10.1016/j.bmc.2013.09.061. Epub 2013 Oct 4. Bioorg Med Chem. 2013. PMID: 24148835
-
Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.Arch Pharm (Weinheim). 2013 Dec;346(12):865-71. doi: 10.1002/ardp.201300074. Epub 2013 Nov 6. Arch Pharm (Weinheim). 2013. PMID: 24203864
-
Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines.Curr Top Med Chem. 2017;17(31):3328-3335. doi: 10.2174/1568026618666180112155639. Curr Top Med Chem. 2017. PMID: 29332586 Review.
-
Therapeutic Potential of Multifunctional Tacrine Analogues.Curr Neuropharmacol. 2019;17(5):472-490. doi: 10.2174/1570159X16666180412091908. Curr Neuropharmacol. 2019. PMID: 29651948 Free PMC article. Review.
Cited by
-
Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment.Curr Neuropharmacol. 2017;15(4):637-653. doi: 10.2174/1570159X14666160607212615. Curr Neuropharmacol. 2017. PMID: 27281175 Free PMC article. Review.
-
Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease.Int J Mol Sci. 2023 Jan 24;24(3):2285. doi: 10.3390/ijms24032285. Int J Mol Sci. 2023. PMID: 36768608 Free PMC article.
-
Tacrine-Based Hybrids: Past, Present, and Future.Int J Mol Sci. 2023 Jan 15;24(2):1717. doi: 10.3390/ijms24021717. Int J Mol Sci. 2023. PMID: 36675233 Free PMC article. Review.
-
The citrus flavonoid "Nobiletin" impedes STZ-induced Alzheimer's disease in a mouse model through regulating autophagy mastered by SIRT1/FoxO3a mechanism.Inflammopharmacology. 2023 Oct;31(5):2701-2717. doi: 10.1007/s10787-023-01292-z. Epub 2023 Aug 19. Inflammopharmacology. 2023. PMID: 37598127 Free PMC article.
-
The flavonoid derivative 2-(4' Benzyloxyphenyl)-3-hydroxy-chromen-4-one protects against Aβ42-induced neurodegeneration in transgenic Drosophila: insights from in silico and in vivo studies.Neurotox Res. 2014 Nov;26(4):331-50. doi: 10.1007/s12640-014-9466-z. Epub 2014 Apr 5. Neurotox Res. 2014. PMID: 24706035
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical